Postexposure rabies prophylaxis completed in 1 week: Preliminary study

Clinical Infectious Diseases

Volumn 50, Issue 1, 2010, Pages 56-60

  Shantavasinkul, Prapimporn ^a   Tantawichien, Thanphet ^a   Wilde, Henry ^a   Sawangvaree, Artikaya ^a   Kumchat, Apinya ^a   Ruksaket, Natthasri ^a   Lohsoonthorn, Vitool ^a   Khawplod, Pakamatz ^a   Tantawichien, Terapong ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

EQUINE RABIES IMMUNOGLOBULIN; NEUTRALIZING ANTIBODY; RABIES IMMUNOGLOBULIN; RABIES VACCINE; UNCLASSIFIED DRUG;

ADULT; AMPOULE; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOGENICITY; INFECTION PREVENTION; INJECTION SITE ERYTHEMA; INJECTION SITE INDURATION; INJECTION SITE PAIN; INJECTION SITE PRURITUS; MALE; NONHUMAN; PRIORITY JOURNAL; RABIES; SERUM SICKNESS; VERO CELL; WORLD HEALTH ORGANIZATION;

ADULT; ANALYSIS OF VARIANCE; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CERCOPITHECUS AETHIOPS; FEMALE; HORSES; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULINS; INJECTIONS, INTRADERMAL; MALE; MIDDLE AGED; POST-EXPOSURE PROPHYLAXIS; PROSPECTIVE STUDIES; RABIES; RABIES VACCINES; VERO CELLS;

EID: 72049103208     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/649211     Document Type: Article

References (25)

1. Warrell DA, Gutiérrez JM, World Health Organization. Rabies and envenomings: a neglected public health issue : report of a consultative meeting, World Health Organization, Geneva, 10 January 2007. Geneva: World Health Organization, 2007.
2. WHO Expert Consultation on rabies. World Health Organ Tech Rep Ser 2005; 931:1-88, back cover.
3. Rabies vaccines. WHO position paper. Wkly Epidemiol Rec 2007; 82: 425-435
4. WHO Expert Committee on biological standardization. World Health Organ Tech Rep Ser 2007; 1-340, back cover.
5. Chutivongse S, Wilde H, Fishbein DB, Baer GM, Hemachudha T. One-year study of the 2-1-1 intramuscular postexposure rabies vaccine regimen in 100 severely exposed Thai patients using rabies immune globulin and Vero cell rabies vaccine. Vaccine 1991; 9:573-576
6. Chutivongse S, Wilde H, Supich C, Baer GM, Fishbein DB. Postexposure prophylaxis for rabies with antiserum and intradermal vaccination. Lancet 1990; 335:896-898 (Pubitemid 20136790)
7. Jaiiaroensup W, Lang J, Thipkong P, et al. Safety and efficacy of purified Vero cell rabies vaccine given intramuscularly and intradermally: results of a prospective randomized trial. Vaccine 1998; 16:1559-1562 (Pubitemid 28366093)
8. Khawplod P, Wilde H, Sirikwin S, et al. Revision of the Thai Red Cross intradermal rabies post-exposure regimen by eliminating the 90-day booster injection. Vaccine 2006; 24:3084-3086
9. Warrell MJ, Nicholson KG, Warrell DA, et al. Economical multiple-site intradermal immunisation with human diploid-cell-strain vaccine is effective for post-exposure rabies prophylaxis. Lancet 1985; 1:1059-1062
10. Wilde H, Tipkong P, Khawplod P. Economic issues in postexposure rabies treatment. J Travel Med 1999; 6:238-242
11. Goswami A, Plun-Favreau J, Nicoloyannis N, Sampath G, Siddiqui MN, Zinsou JA. The real cost of rabies post-exposure treatments. Vaccine 2005; 23:2970-2976 (Pubitemid 40462435)
12. Thraenhart O, Marcus I, Scheiermann N, et al. 3-1 scheme, a regimen of only two clinic visits with optimal antibody and interferon-induction. In: Thraenhart O, Koprowski H, eds. Progress in rabies control. Kent, England: Wells Medical, 1989:536-547
13. Khawplod P, Wilde H, Tepsumethanon S, et al. Prospective immunogenicity study of multiple intradermal injections of rabies vaccine in an effort to obtain an early immune response without the use of immunoglobulin. Clin Infect Dis 2002; 35:1562-1565 (Pubitemid 36020703)
14. Tantawichien T, Benjavongkulchai M, Wilde H, et al. Value of skin testing for predicting reactions to equine rabies immune globulin. Clin Infect Dis 1995; 21:660-662
15. Smith JS, Yager PA, Baer GM. A rapid reproducible test for determining rabies neutralizing antibody. Bull World Health Organ 1973; 48:535-541
16. Benjavongkulchai M, Kositprapa C, Limsuwun K, et al. An immunogenicity and efficacy study of purified chick embryo cell culture rabies vaccine manufactured in Japan. Vaccine 1997; 15:1816-1819 (Pubitemid 27504673)
17. Briggs DJ, Banzhoff A, Nicolay U, et al. Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine. Bull World Health Organ 2000; 78:693-698 (Pubitemid 30398852)
18. Charanasri U, Meesomboon V, Kingnate D, Samuthananont P, Chaeychomsri W. Intradermal simulated rabies postexposure prophylaxis using purified chick embryo rabies vaccine. J Med Assoc Thai 1994; 77: 157-160
19. Wilde H, Glueck R, Khawplod P, et al. Efficacy study of a new albumin-free human diploid cell rabies vaccine (Lyssavac-HDC, Berna) in 100 severely rabies-exposed Thai patients. Vaccine 1995; 13:593-596
20. Wilde H, Chutivongse S. Equine rabies immune globulin: a product with an undeserved poor reputation. Am J Trop Med Hyg 1990; 42:175-178 (Pubitemid 20093451)
21. Hemachudha T, Laothamatas J, Rupprecht CE. Human rabies: a disease of complex neuropathogenetic mechanisms and diagnostic challenges. Lancet Neurol 2002; 1:101-109 (Pubitemid 37163495)
22. Zoonoses control: WHO consultation on intradermal application of human rabies vaccines. Wkly Epidemiol Rec 1995; 70:336-338
23. Nicolas JF, Guy B. Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice. Expert Rev Vaccines 2008; 7:1201-1214
24. Phanuphak P, Khawplod P, Sirivichayakul S, Siriprasomsub W, Ubol S, Thaweepathomwat M. Humoral and cell-mediated immune responses to various economical regimens of purified Vero cell rabies vaccine. Asian Pac J Allergy Immunol 1987; 5:33-37
25. Ratanavongsiri J, Sriwanthana B, Ubol S, Phanuphak P. Cell-mediated immune response following intracutaneous immunisation with human diploid cell rabies vaccine. Asian Pac J Allergy Immunol 1985; 3:187-190 (Pubitemid 16200237)